We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+28.05%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$10.3B
AUM Growth
+$5.25B
Cap. Flow
+$4.62B
Cap. Flow %
45%
Top 10 Hldgs %
41.75%
Holding
2,600
New
918
Increased
493
Reduced
472
Closed
701

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$353M
2
MSFT icon
Microsoft
MSFT
+$352M
3
AAPL icon
Apple
AAPL
+$256M
4
BABA icon
Alibaba
BABA
+$189M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$125M

Sector Composition

Rank Sector Weight
1 Technology 14.28%
2 Consumer Discretionary 10.77%
3 Healthcare 5.09%
4 Industrials 4.03%
5 Financials 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHT
1376
Universal Health Realty Income Trust
UHT
$582M
$405K ﹤0.01%
6,297
-2,159
-26% -$131K
CURO
1377
DELISTED
CURO Group Holdings Corp.
CURO
$404K ﹤0.01%
+28,211
New +$260K
ALNY icon
1378
Alnylam Pharmaceuticals
ALNY
$31.6B
$403K ﹤0.01%
+3,101
New +$414K
IBP icon
1379
Installed Building Products
IBP
$6.51B
$403K ﹤0.01%
+3,949
New +$403K
MAS icon
1380
Masco
MAS
$14.4B
$401K ﹤0.01%
7,301
-24,090
-77% -$1.33M
UPST icon
1381
Upstart Holdings
UPST
$2.91B
$400K ﹤0.01%
+9,825
New +$403K
LBAI
1382
DELISTED
Lakeland Bancorp Inc
LBAI
$400K ﹤0.01%
+31,490
New +$371K
CHEF icon
1383
Chefs' Warehouse
CHEF
$4.63B
$398K ﹤0.01%
+15,486
New +$305K
ANGO icon
1384
AngioDynamics
ANGO
$652M
$397K ﹤0.01%
+25,924
New +$329K
BEAT
1385
DELISTED
BioTelemetry, Inc.
BEAT
$397K ﹤0.01%
5,513
+80
+1% +$4.19K
BLDR icon
1386
Builders FirstSource
BLDR
$7.56B
$396K ﹤0.01%
9,711
-10,605
-52% -$376K
KGC icon
1387
Kinross Gold
KGC
$39.1B
$396K ﹤0.01%
53,908
-75,580
-58% -$602K
MTLS
1388
Materialise
MTLS
$387M
$396K ﹤0.01%
+7,302
New +$325K
PATK icon
1389
Patrick Industries
PATK
$2.73B
$395K ﹤0.01%
+8,666
New +$367K
RRX icon
1390
Regal Rexnord
RRX
$10.8B
$395K ﹤0.01%
3,219
-14,069
-81% -$1.55M
OSH
1391
DELISTED
Oak Street Health, Inc.
OSH
$395K ﹤0.01%
+6,453
New +$339K
EPZM
1392
DELISTED
Epizyme, Inc
EPZM
$395K ﹤0.01%
36,402
+22,084
+154% +$272K
MLTX icon
1393
MoonLake Immunotherapeutics
MLTX
$1.31B
$393K ﹤0.01%
+34,551
New +$367K
SNX icon
1394
TD Synnex
SNX
$19.5B
$393K ﹤0.01%
4,823
-3,293
-41% -$252K
HMSY
1395
DELISTED
HMS Holdings Corp.
HMSY
$393K ﹤0.01%
10,703
-1,251
-10% -$38K
EGO icon
1396
Eldorado Gold
EGO
$12.1B
$391K ﹤0.01%
29,433
+4,217
+17% +$54.1K
UEIC icon
1397
Universal Electronics
UEIC
$56.8M
$391K ﹤0.01%
+7,462
New +$345K
VRNS icon
1398
Varonis Systems
VRNS
$4.72B
$391K ﹤0.01%
7,164
-2,196
-23% -$95.3K
GME icon
1399
GameStop
GME
$8.09B
$389K ﹤0.01%
82,660
-188,076
-69% -$647K
XYL icon
1400
Xylem
XYL
$26.7B
$389K ﹤0.01%
+3,817
New +$359K

Similar funds

Michael Gelband's Q4 2020 Portfolio in Review

As of Q4 2020, Michael Gelband held 2,600 positions worth $10.3B, up 105% from $5.02B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Michael Gelband deployed $4.62B of net new capital in Q4 2020, opening 918 new positions and adding to 493 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Charles Schwab, an estimated $82M trimmed.

  • Michael Gelband's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.
  • Michael Gelband added most to Amazon in Q4 2020, an estimated $353M increase.
  • Michael Gelband's biggest Q4 2020 reduction was Charles Schwab, cutting an estimated $82M.
  • Michael Gelband fully exited Eli Lilly in Q4 2020, selling an estimated $21.7M.
  • Michael Gelband's ten largest holdings make up 42% of its $10.3B portfolio in Q4 2020.
  • Michael Gelband opened 918 new positions and closed 701 in Q4 2020.
  • Michael Gelband's portfolio value rose 105% quarter-over-quarter to $10.3B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.